Global microbiology testing market set to grow at 9% CAGR, reaching $13.7B by 2034 driven by infectious disease demand.

The global microbiology testing market is projected to grow rapidly at a compound annual growth rate (CAGR) of approximately 9% from 2026 to 2034, reaching a market size of $13.7 billion by 2034. This growth is driven by the rising prevalence of infectious diseases, increasing healthcare expenditure, and advancements in diagnostic technologies such as molecular diagnostics and automated systems. North America currently leads the market, supported by advanced healthcare infrastructure and regulatory standards, while Asia-Pacific is expected to record the fastest growth due to expanding healthcare access and stringent safety regulations. The market also benefits from growing demand in food safety, pharmaceutical production, and environmental monitoring sectors.

As the global microbiology testing market is set for rapid growth, shares of key players like Agilent Technologies Inc are showing steady performance. On Pluang, Agilent trades at USD 172.48 with a 1-day gain of 0.49% as of Oct 15, 2026 00:22 WIB. The stock remains close to its 52-week high of USD 175.19, reflecting investor confidence in the health sector's expansion.